ABSTRACT
A 74-year-old man recently diagnosed with high-risk prostate cancer with high serum prostate specific antigen was referred to nuclear medicine for a technetium-99m-methylene diphosphonate (Tc-99m MDP) bone scan. On delayed three-hour anterior planar image, an unexpected round focus of intense uptake was found overlying the right orbit. Single-photon emission computed tomography/computed tomography localized the uptake to an ocular prosthesis. The hydroxyapatite composition of the ocular implant can be recognized by its bone-like density and its intense accumulation of Tc-99m MDP. Review of the patient’s history revealed remote right eye evisceration secondary to a complication of cataract surgery, consistent with the findings.
References
1Gradinaru S, Popescu V, Leasu C, Pricopie S, Yasin S, Ciuluvica R, Ungureanu E. Hydroxyapatite ocular implant and non-integrated implants in eviscerated patients. J Med Life 2015;8:90-93.
2Civelek AC, Pacheco EM, Natarajan TK, Wagner HN Jr, Iliff NT. Quantitative measurement of vascularization and vascular in growth rate of coralline hydroxyapatite ocular implant by Tc-99m MDP bone imaging. Clin Nucl Med 1995;20:779-787.
3Numerow LM, Kloiber R, Mitchell RJ, Molnar CP, Anderson MA. Hydroxyapatite orbital implants. Scanning with technetium-99m MDP. Clin Nucl Med 1994;19:9-12.
4Menzel C, Grünwald F, Busin M, Mönks T, Hotze AL, Schomburg A, Pavics L, Biersack HJ. Vascularisation of ocular coralline hydroxyapatite implants. Eur J Nucl Med 1994;21:1343-1345.
5Leitha T, Staudenherz A, Scholz U. Three-phase bone scintigraphy of hydroxyapatite ocular implants. Eur J Nucl Med 1995;22:308-314.
